Interventions to Mitigate Chemotherapy Side Effects in Lung Cancer Patients
DOI:
https://doi.org/10.47611/jsrhs.v12i4.5476Keywords:
Key words: chemotherapy, side effects, natural molecules, diet intervention, gut microbiota, combined therapyAbstract
Lung cancer remains a formidable challenge in oncology, necessitating innovative and comprehensive therapeutic approaches. Lung cancer treatment encompasses diverse modalities such as chemotherapy, radiotherapy, targeted therapy, and immunotherapy. Chemotherapy continues to stand as a fundamental treatment approach, yet the consequential side effects it brings forth pose significant barriers to its broad implementation and serve as a primary impediment in clinical practice. This review presents a detailed exploration of natural molecules, dietary strategies, and their potential to enhance chemotherapy's efficacy and mitigate adverse effects. Moreover, the significance of combined therapies emerges, elucidating their capacity to synergistically combat lung cancer through enhanced treatment efficacy, resistance prevention, and personalized patient care. This paper also underscores the value of adjuvant therapy and its role in extending patient survival and reducing recurrence rates. In addition, the interplay between gut microbiota and chemotherapy outcomes is examined, emphasizing the potential for microbiota modulation to optimize treatment responses. Conclusively, this comprehensive review underscores the dynamic landscape of lung cancer treatment, advocating for a holistic approach that integrates cutting-edge therapeutic paradigms to enhance patient outcomes and quality of life.
Downloads
References or Bibliography
Ahmed, S., Sulaiman, S. A., Baig, A. A., Ibrahim, M., Liaqat, S., Fatima, S., . . . Othman, N. H. (2018). Honey as a Potential Natural Antioxidant Medicine: An Insight into Its Molecular Mechanisms of Action. Oxid Med Cell Longev, 2018, 8367846. doi:10.1155/2018/8367846
Altun, I., & Sonkaya, A. (2018). The Most Common Side Effects Experienced by Patients Were Receiving First Cycle of Chemotherapy. Iran J Public Health, 47(8), 1218-1219. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30186799
Amoedo, N. D., Valencia, J. P., Rodrigues, M. F., Galina, A., & Rumjanek, F. D. (2013). How does the metabolism of tumour cells differ from that of normal cells. Biosci Rep, 33(6). doi:10.1042/BSR20130066
Birring, S. S., & Peake, M. D. (2005). Symptoms and the early diagnosis of lung cancer. Thorax, 60(4), 268-269. doi:10.1136/thx.2004.032698
Brandhorst, S. (2021). Fasting and fasting-mimicking diets for chemotherapy augmentation. Geroscience, 43(3), 1201-1216. doi:10.1007/s11357-020-00317-7
Brandhorst, S., & Longo, V. D. (2016). Fasting and Caloric Restriction in Cancer Prevention and Treatment. Recent Results Cancer Res, 207, 241-266. doi:10.1007/978-3-319-42118-6_12
Bringman-Rodenbarger, L. R., Guo, A. H., Lyssiotis, C. A., & Lombard, D. B. (2018). Emerging Roles for SIRT5 in Metabolism and Cancer. Antioxid Redox Signal, 28(8), 677-690. doi:10.1089/ars.2017.7264
Cao, J., Han, J., Xiao, H., Qiao, J., & Han, M. (2016). Effect of Tea Polyphenol Compounds on Anticancer Drugs in Terms of Anti-Tumor Activity, Toxicology, and Pharmacokinetics. Nutrients, 8(12). doi:10.3390/nu8120762
Chen, D., Wu, J., Jin, D., Wang, B., & Cao, H. (2019). Fecal microbiota transplantation in cancer management: Current status and perspectives. Int J Cancer, 145(8), 2021-2031. doi:10.1002/ijc.32003
Cooper, W. A., Lam, D. C., O'Toole, S. A., & Minna, J. D. (2013). Molecular biology of lung cancer. J Thorac Dis, 5 Suppl 5(Suppl 5), S479-490. doi:10.3978/j.issn.2072-1439.2013.08.03
Freitas, R. D. S., & Campos, M. M. (2019). Protective Effects of Omega-3 Fatty Acids in Cancer-Related Complications. Nutrients, 11(5). doi:10.3390/nu11050945
Gaurav, K., Goel, R. K., Shukla, M., & Pandey, M. (2012). Glutamine: A novel approach to chemotherapy-induced toxicity. Indian J Med Paediatr Oncol, 33(1), 13-20. doi:10.4103/0971-5851.96962
Giaccone, G., & He, Y. (2023). Current knowledge of small cell lung cancer transformation from non-small cell lung cancer. Semin Cancer Biol, 94, 1-10. doi:10.1016/j.semcancer.2023.05.006
Grant, C., Hagopian, G., & Nagasaka, M. (2023). Neoadjuvant Therapy in Non-Small Cell Lung Cancer. Crit Rev Oncol Hematol, 104080. doi:10.1016/j.critrevonc.2023.104080
Henry, D. H., Viswanathan, H. N., Elkin, E. P., Traina, S., Wade, S., & Cella, D. (2008). Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer, 16(7), 791-801. doi:10.1007/s00520-007-0380-2
Hirsch, F. R., Scagliotti, G. V., Mulshine, J. L., Kwon, R., Curran, W. J., Jr., Wu, Y. L., & Paz-Ares, L. (2017). Lung cancer: current therapies and new targeted treatments. Lancet, 389(10066), 299-311. doi:10.1016/S0140-6736(16)30958-8
Inamura, K. (2017). Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification. Front Oncol, 7, 193. doi:10.3389/fonc.2017.00193
Kennel, K. A., & Drake, M. T. (2013). Vitamin D in the cancer patient. Curr Opin Support Palliat Care, 7(3), 272-277. doi:10.1097/SPC.0b013e3283640f74
Kumar Singh, A., Cabral, C., Kumar, R., Ganguly, R., Kumar Rana, H., Gupta, A., . . . Pandey, A. K. (2019). Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency. Nutrients, 11(9). doi:10.3390/nu11092216
Lemjabbar-Alaoui, H., Hassan, O. U., Yang, Y. W., & Buchanan, P. (2015). Lung cancer: Biology and treatment options. Biochim Biophys Acta, 1856(2), 189-210. doi:10.1016/j.bbcan.2015.08.002
Lin, Z., & Fang, D. (2013). The Roles of SIRT1 in Cancer. Genes Cancer, 4(3-4), 97-104. doi:10.1177/1947601912475079
Liu, Z., Huang, P., Law, S., Tian, H., Leung, W., & Xu, C. (2018). Preventive Effect of Curcumin Against Chemotherapy-Induced Side-Effects. Front Pharmacol, 9, 1374. doi:10.3389/fphar.2018.01374
Ma, W., Mao, Q., Xia, W., Dong, G., Yu, C., & Jiang, F. (2019). Gut Microbiota Shapes the Efficiency of Cancer Therapy. Front Microbiol, 10, 1050. doi:10.3389/fmicb.2019.01050
Mentella, M. C., Scaldaferri, F., Ricci, C., Gasbarrini, A., & Miggiano, G. A. D. (2019). Cancer and Mediterranean Diet: A Review. Nutrients, 11(9). doi:10.3390/nu11092059
Nooreldeen, R., & Bach, H. (2021). Current and Future Development in Lung Cancer Diagnosis. Int J Mol Sci, 22(16). doi:10.3390/ijms22168661
O'Flanagan, C. H., Smith, L. A., McDonell, S. B., & Hursting, S. D. (2017). When less may be more: calorie restriction and response to cancer therapy. BMC Med, 15(1), 106. doi:10.1186/s12916-017-0873-x
Pinedo, H. M., & Giaccone, G. (1997). Chemotherapy. Lancet, 349 Suppl 2, SII7-9. doi:10.1016/s0140-6736(97)90012-x
Sangha, R., Price, J., & Butts, C. A. (2010). Adjuvant therapy in non-small cell lung cancer: current and future directions. Oncologist, 15(8), 862-872. doi:10.1634/theoncologist.2009-0186
Thandra, K. C., Barsouk, A., Saginala, K., Aluru, J. S., & Barsouk, A. (2021). Epidemiology of lung cancer. Contemp Oncol (Pozn), 25(1), 45-52. doi:10.5114/wo.2021.103829
Wu, L., Leng, D., Cun, D., Foged, C., & Yang, M. (2017). Advances in combination therapy of lung cancer: Rationales, delivery technologies and dosage regimens. J Control Release, 260, 78-91. doi:10.1016/j.jconrel.2017.05.023
Zhang, Y. J., Li, S., Gan, R. Y., Zhou, T., Xu, D. P., & Li, H. B. (2015). Impacts of gut bacteria on human health and diseases. Int J Mol Sci, 16(4), 7493-7519. doi:10.3390/ijms16047493
Published
How to Cite
Issue
Section
Copyright (c) 2023 Wenlu Li
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
